Activation of the Farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential.
about
Farnesoid X receptor ligand CDCA suppresses human prostate cancer cells growth by inhibiting lipid metabolism via targeting sterol response element binding protein 1.Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells.
P2860
Activation of the Farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Activation of the Farnesoid X- ...... increased migration potential.
@en
Activation of the Farnesoid X- ...... increased migration potential.
@en-gb
type
label
Activation of the Farnesoid X- ...... increased migration potential.
@en
Activation of the Farnesoid X- ...... increased migration potential.
@en-gb
prefLabel
Activation of the Farnesoid X- ...... increased migration potential.
@en
Activation of the Farnesoid X- ...... increased migration potential.
@en-gb
P2093
P1154
2-s2.0-84949494627
P1433
P1476
Activation of the Farnesoid X- ...... increased migration potential.
@en
P2093
Karen E Swales
Noura Alasmael
Rati Mohan
P304
P356
10.1016/J.CANLET.2015.10.031
P407
P5530
P577
2015-11-03T00:00:00Z
P5875
P6179
1021412733